Acceleron Pharma Inc. (XLRN) Financials

NASDAQ Currency in USD Disclaimer

$178.75

north_east NA Past Year
Day's range
$177.2
Day's range
$179.85
$100M$100M$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200MEarning20142014201520152016201620172017201820182019201920202020200%200%0%0%-200%-200%-400%-400%-600%-600%-800%-800%-1000%-1000%Profit Margin
Profit Margin
Revenue
Earnings

XLRN Income statement / Annual

Last year (2020), Acceleron Pharma Inc.'s total revenue was $92.52 M, an increase of 25.04% from the previous year. In 2020, Acceleron Pharma Inc.'s net income was -$166.03 M. See Acceleron Pharma Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012 FY-2011
Period Ended 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012 12/31/2011
Operating Revenue $92.52 M $73.99 M $13.99 M $13.48 M $27.77 M $18.10 M $14.63 M $57.23 M $15.25 M $80.91 M
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $92.52 M $73.99 M $13.99 M $13.48 M $27.77 M $18.10 M $14.63 M $57.23 M $15.25 M $80.91 M
Gross Profit Ratio 1 1 1 1 1 1 1 1 1 1
Research and Development Expenses $173.92 M $153.95 M $103.90 M $89.73 M $68.58 M $58.40 M $50.90 M $36.05 M $35.32 M $32.71 M
General & Administrative Expenses $0.00 $0.00 $34.50 M $33.74 M $25.30 M $20.57 M $14.20 M $14.23 M $8.82 M $8.14 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $0.00 $0.00 $34.50 M $33.74 M $25.30 M $20.57 M $14.20 M $14.23 M $8.82 M $8.14 M
Other Expenses $85.91 M $56.49 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $259.83 M $210.44 M $138.41 M $123.46 M $93.88 M $78.98 M $65.10 M $50.28 M $44.14 M $40.86 M
Cost And Expenses $259.83 M $210.44 M $138.41 M $123.46 M $93.88 M $78.98 M $65.10 M $50.28 M $44.14 M $42.36 M
Interest Income $2.87 M $10.71 M $5.57 M $2.55 M $1.85 M $512,000.00 $83,000.00 $39,000.00 $91,000.00 $17,000.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $922,000.00 $2.09 M $1.53 M $1.82 M
Depreciation & Amortization $3.85 M $3.94 M $3.75 M $2.83 M $1.68 M $1.18 M $1.12 M $915,000.00 $1.29 M $3.13 M
EBITDA -$162.16 M -$120.98 M -$115.15 M -$105.60 M -$55.31 M -$62.72 M -$49.22 M -$18.89 M -$29.76 M $41.22 M
EBITDA Ratio -1.75 -1.64 -8.23 -7.83 -1.99 -3.47 -3.36 -0.33 -1.95 0.51
Operating Income Ratio -1.81 -1.84 -8.89 -8.16 -2.38 -3.36 -3.45 0.12 -1.89 0.48
Total Other Income/Expenses Net $1.30 M $11.53 M $5.52 M $1.56 M $9.12 M -$3.02 M -$795,000.00 -$28.85 M -$3.69 M -$2.29 M
Income Before Tax -$166.01 M -$124.92 M -$118.90 M -$108.42 M -$56.99 M -$63.89 M -$51.26 M -$21.90 M -$32.58 M $36.27 M
Income Before Tax Ratio -1.79 -1.69 -8.5 -8.04 -2.05 -3.53 -3.5 -0.38 -2.14 0.45
Income Tax Expense $21,000.00 -$62,000.00 -$27,000.00 $32,000.00 $24,000.00 -$3.02 M $127,000.00 -$26.76 M -$2.16 M -$468,000.00
Net Income -$166.03 M -$124.86 M -$118.87 M -$108.45 M -$57.01 M -$63.89 M -$51.26 M -$21.90 M -$32.58 M $36.27 M
Net Income Ratio -1.79 -1.69 -8.5 -8.04 -2.05 -3.53 -3.5 -0.38 -2.14 0.45
EPS -2.92 -2.38 -2.59 -2.68 -1.52 -1.92 -1.63 -1.04 -1.55 1.73
EPS Diluted -2.92 -2.38 -2.59 -2.68 -1.52 -1.92 -1.63 -1.04 -1.55 1.58
Weighted Average Shares Out $56.80 M $52.45 M $45.90 M $40.42 M $37.43 M $33.30 M $31.52 M $21.06 M $21.06 M $20.95 M
Weighted Average Shares Out Diluted $56.80 M $52.45 M $45.90 M $40.42 M $37.43 M $33.30 M $31.52 M $21.06 M $21.06 M $22.97 M
Link